https://www.selleckchem.com/pr....oducts/ganetespib-st
33-3.51) and total cholesterol (MD -12.45, 95% CI -22.05 to -2.85). In contrast, there is no statistically significant difference in the improvement in low-density lipoprotein (MD -6.02, 95% CI -26.66 to 14.62) and triglyceride (MD 8.22, 95% CI -26.10 to 42.53) between curcumin and placebo. The results of the fasting glucose, fasting insulin, HOMA-IR, QUICKI, and total cholesterol are conclusive as indicated by the trial sequential analysis. Curcumin may improve glycemic control and lipid metabolism in patients with PCOS and